Recently, a decreased number of CD8+ T cells, with no changes in CD4+ T cell numbers, was observed in stroke patients with a history of HT and a decreased number of CD8+ T cells in patients with HT from the control group in comparison to patients without HT diagnosis (Adamski et al., 2014). The gene discussed is CD8A; the disease is hematocrit.